Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Particle-mediated delivery of H5N1 vaccine holds promise for the prophylaxis of influenza

Aug. 13, 2007

ImmuneRegen BioSciences finalizes material transfer agreement with VaxGen

Aug. 9, 2007

Long-term use of Isotechnika's ISA-247 in phase IIb trial allowed by FDA

Aug. 9, 2007

North American clinical evaluation of GSK prepandemic H5N1 vaccine commences

Aug. 8, 2007

Univ. Birmingham selects Eden Biodesign to develop and produce novel autoimmune disease drug

Aug. 7, 2007

Inactivated whole-virion SARS vaccine immunogenic and protective in hamster model

Aug. 6, 2007

AlphaVax proceeds with the development of a smallpox vaccine

Aug. 6, 2007

Live, attenuated SARS vaccine provides protection against lung infection in hamsters

Aug. 2, 2007

Phase II trial of single-dose, oral Ty-800 typhoid vaccine begins

Aug. 2, 2007

New drugs for immunological disorders divulged in recent Japanese patents

Aug. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
Anle-138b reduces mHTT aggregation, improves pathological phenotypes in Huntington’s models
BioWorld Science
Anle-138b (emrusolmin) is a diphenylpyrazole compound that directly interacts with oligomeric species of disease-related aggregating proteins, reducing aggregate...